Celcuity CELC
NASDAQ CELC
$95.70 -0.73 (-0.76%)
As of: Sep 4, 2026 · 3:59 PM EDT

Celcuity (CELC) Share-based Compensation (2016 - 2026)

Celcuity's (CELC) quarterly Share-based Compensation came in at $9.5 million in Q4 2025, up 308.47% YoY from $2.3 million in Q4 2024, and up 39.49% on a QoQ basis from $6.8 million in Q3 2025.

Analysis

Celcuity (CELC) Share-based Compensation (2016 - 2026) Analysis & Trends

Celcuity (CELC) has 10 years of Share-based Compensation data on file, last reported at $9.5 million in Q4 2025.

  • Quarterly Share-based Compensation rose 308.47% year-over-year to $9.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.4 million (up 206.0% YoY) and the FY2025 annual result came in at $21.4 million, up 206.0% from the prior year.
  • Share-based Compensation grew to $9.5 million in Q4 2025, from $6.8 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $9.5 million in Q4 2025 to a low of $449098.0 in Q1 2021.
  • A 5-year average of $2.1 million and a median of $1.3 million in 2023 frame the typical range for Share-based Compensation.
  • Annual changes were most pronounced in 2023 — Share-based Compensation decreased 15.96% — and 2025, when it surged 308.47%.
  • Tracing CELC's Share-based Compensation over 5 years: stood at $699916.0 in 2021, then jumped by 62.79% to $1.1 million in 2022, then advanced by 9.05% to $1.2 million in 2023, then jumped by 86.31% to $2.3 million in 2024, then surged by 308.47% to $9.5 million in 2025.
  • The last three Share-based Compensation figures came in at $9.5 million (Q4 2025), $6.8 million (Q3 2025), and $2.7 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 Celcuity 5.25 Bn 5.25 Bn - 6.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.90 Mn
Dec 31, 2025 9.46 Mn
Sep 30, 2025 6.78 Mn
Jun 30, 2025 3.00 Mn
Mar 31, 2025 4.85 Mn
Dec 31, 2024 2.32 Mn
Sep 30, 2024 4.21 Mn
Jun 30, 2024 3.27 Mn
Mar 31, 2024 3.05 Mn
Dec 31, 2023 1.24 Mn
Sep 30, 2023 2.70 Mn
Jun 30, 2023 2.19 Mn
Mar 31, 2023 2.07 Mn
Dec 31, 2022 1.14 Mn
Sep 30, 2022 1.92 Mn
Jun 30, 2022 1.78 Mn
Mar 31, 2022 1.35 Mn
Dec 31, 2021 920,604.00
Sep 30, 2021 1.18 Mn
Jun 30, 2021 1.02 Mn